It looks like this equity (IPATF) cannot be resolved or is no longer available, but we have found another equity that may match the characteristics of what you are looking for. Please check IPA Immunoprecise Antibodies to make sure you are using current equity.
IMMUNOPRECISE ANTIBODIES LTD cannot be verified against its exchange. It appears that IMMUNOPRECISE ANTIBODIES is not available for investing at the moment. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.


Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. IMMUNOPRECISE ANTIBODIES's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding IMMUNOPRECISE ANTIBODIES or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
IMMUNOPRECISE ANTIBODIES is now traded under the symbol IPA. Please update your portfolios or report it if you believe this is an error. Report It!
New SymbolIPA
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of IMMUNOPRECISE ANTIBODIES's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
IMMUNOPRECISE ANTIBODIES LTD (IPATF) is traded on NASDAQ Exchange in USA and employs 4 people. The company currently falls under 'Small-Cap' category with current market capitalization of 313.25 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate IMMUNOPRECISE ANTIBODIES's market, we take the total number of its shares issued and multiply it by IMMUNOPRECISE ANTIBODIES's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. IMMUNOPRECISE ANTIBODIES classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 16.76 M outstanding shares. IMMUNOPRECISE ANTIBODIES LTD has accumulated about 1.77 M in cash with (1.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03.
Check IMMUNOPRECISE ANTIBODIES Probability Of Bankruptcy

IMMUNOPRECISE Stock Against Markets

Picking the right benchmark for IMMUNOPRECISE ANTIBODIES stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in IMMUNOPRECISE ANTIBODIES stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for IMMUNOPRECISE ANTIBODIES is critical whether you are bullish or bearish towards IMMUNOPRECISE ANTIBODIES LTD at a given time.
IMMUNOPRECISE ANTIBODIES LTD cannot be verified against its exchange. It appears that IMMUNOPRECISE ANTIBODIES is not available for investing at the moment. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.

Try Other Stock Suggestions

Delisting Warning - IPATF


  The entity IMMUNOPRECISE ANTIBODIES LTD with a symbol IPATF was delisted from NASDAQ Exchange. Please use Immunoprecise Antibodies with a symbol IPA from now on.


You need to understand the risk of investing before taking a position in IMMUNOPRECISE ANTIBODIES. The danger of trading IMMUNOPRECISE ANTIBODIES LTD is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of IMMUNOPRECISE ANTIBODIES is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than IMMUNOPRECISE ANTIBODIES. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile IMMUNOPRECISE ANTIBODIES is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Risk vs Return Analysis. Note that the IMMUNOPRECISE ANTIBODIES information on this page should be used as a complementary analysis to other IMMUNOPRECISE ANTIBODIES's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Focused Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Tools for IMMUNOPRECISE Stock

When running IMMUNOPRECISE ANTIBODIES price analysis, check to measure IMMUNOPRECISE ANTIBODIES's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IMMUNOPRECISE ANTIBODIES is operating at the current time. Most of IMMUNOPRECISE ANTIBODIES's value examination focuses on studying past and present price action to predict the probability of IMMUNOPRECISE ANTIBODIES's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move IMMUNOPRECISE ANTIBODIES's price. Additionally, you may evaluate how the addition of IMMUNOPRECISE ANTIBODIES to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments